Personal genomics company 23andMe has received a patent covering its Family Traits Inheritance Calculator tool that lets prospective parents see what traits their children may inherit.
Teva Pharmaceutical Industries has claimed victory in a patent revocation action brought by generic drug maker Mylan in the Hague over its blockbuster Copaxone drug, used in the treatment of multiple sclerosis.
Swedish law firm Vinge has hired IP specialist Ulf Dahlgren to its Stockholm office from rivals Lindahl, following Håkan Borgenhäll’s move from the same firm in April.
Mylan Inc will be forced to divest injectable generic drugs before it can complete a proposed $1.85 billion acquisition of Agila Specialities Global Pte Ltd and Agila Specialties Pvt Ltd after the FTC applied conditions to the deal.
US law firm Baker Botts has expanded its Houston office with the addition of IP litigator Nicolas Barzoukas.
India’s drug patent policy has been slammed by US companies who are insisting that action be taken in order to improve trade relations.
A federal judge has denied AstraZeneca’s motions to dismiss claims challenging its pay-for-delay deals with three generic pharmaceutical companies in connection to heartburn drug Nexium.
A US company which provides secure personal medical records online has filed a patent infringement case against a rival health-care company.
The government in South Africa is considering changing its national policy on IP, a move that could have far reaching effects for its patents system.
A Japanese research institution has collaborated with three Indian organisations to launch two new virtual centres for scientists and students.